Dynamics and heterogeneity of early viral infection

This project aims to enhance imaging technology to study early infection processes of negative-sense RNA viruses, focusing on RSV to understand viral propagation and inform therapeutic strategies.

Subsidie
€ 2.000.000
2023

Projectdetails

Introduction

Viruses are simple replicative units built from two components: a nucleic acid and a small number of associated proteins. Upon entering a cell, viruses co-opt the host's machineries to copy their genetic material, while shutting down the host's antiviral immune response. The success of viral infection differs dramatically from cell to cell through poorly understood mechanisms, resulting in heterogeneous propagation through tissues, and ultimately, heterogeneous disease progression.

Challenges in Studying Viral Infection

Although viruses have been studied for decades, the earliest steps of cellular infection have remained hidden. This is because only a few viral molecules are present at this stage, which presents formidable challenges for molecular analyses. Yet these initial events are critical for achieving a successful infection; transcription, translation, and replication must be perfectly balanced to rapidly scale virus production before antiviral signaling pathways are activated.

Technological Advancements

To overcome this barrier, we recently developed a first-in-kind imaging technology for simple positive-sense single-stranded RNA (+ssRNA) viruses that transforms our ability to visualize early viral infection processes.

Proposal Overview

In this proposal, we will expand our single-molecule toolbox to gain molecular insights into early viral infection of the more complex group of negative-sense RNA (-ssRNA) viruses. We will focus on the respiratory syncytial virus (RSV), a -ssRNA virus which can be deadly in infants and vulnerable adults, and lacks effective treatments.

Research Objectives

Specifically, we will determine:

  1. How viral transcription and replication are coordinated on single viral genomic RNA molecules to optimize early viral propagation.
  2. What causes the early viral infection heterogeneity.
  3. How heterogeneity in early viral infection impacts infection outcome.

Expected Outcomes

Using our novel approaches, we will gain a deep understanding of viral biology, which will eventually inform therapeutic interventions.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.000.000
Totale projectbegroting€ 2.000.000

Tijdlijn

Startdatum1-1-2023
Einddatum31-12-2027
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN - KNAWpenvoerder

Land(en)

Netherlands

Vergelijkbare projecten binnen European Research Council

ERC STG

MANUNKIND: Determinants and Dynamics of Collaborative Exploitation

This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.

€ 1.497.749
ERC STG

Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure

The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.

€ 1.498.280
ERC STG

Uncovering the mechanisms of action of an antiviral bacterium

This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.

€ 1.500.000
ERC STG

The Ethics of Loneliness and Sociability

This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.

€ 1.025.860

Vergelijkbare projecten uit andere regelingen

ERC STG

Interrogating RNA-protein interactions underlying SARS-CoV-2 infection and antiviral defense

This project aims to decode RNA-protein interactions in SARS-CoV-2 to understand its replication cycle and identify potential antiviral targets for treating viral diseases.

€ 1.500.000
ERC ADG

Illuminating the enteroviral life cycle

This project aims to develop novel recombinant reporter viruses for real-time imaging of enterovirus life cycle dynamics, enhancing understanding for antiviral drug development.

€ 2.396.392
ERC ADG

Molecular dissection of viral genomes for future antiviral treatments

This project aims to identify and characterize virus-encoded transmembrane proteins as novel pharmaceutical targets for antiviral drug discovery and treatment of viral infections.

€ 2.420.301
ERC POC

Virus Inhibition by siRNA Optimized by NMR

This project aims to develop a novel class of siRNA molecules targeting SARS-CoV-2 variants using structural biology, with potential applications for other pathogenic viruses.

€ 150.000